![Jeffrey N. Meshulam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey N. Meshulam
President at Profectus BioSciences, Inc.
Jeffrey N. Meshulam active positions
Companies | Position | Start | End |
---|---|---|---|
Profectus BioSciences, Inc.
![]() Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Director/Board Member | - | - |
President | 01/01/2013 | - | |
Chief Operating Officer | 01/01/2005 | - |
Career history of Jeffrey N. Meshulam
Former positions of Jeffrey N. Meshulam
Companies | Position | Start | End |
---|---|---|---|
Institute of Human Virology
![]() Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Corporate Officer/Principal | 01/01/1996 | 01/01/2004 |
Cellular Products, Inc.
![]() Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Chief Executive Officer | 01/01/1983 | 01/01/1996 |
Chairman | 01/01/1996 | 01/01/1996 | |
Founder | 01/01/1996 | 01/01/1996 | |
President | - | 01/01/1996 | |
International Retrovirology Association | Corporate Officer/Principal | - | - |
American Diabetes Association
![]() American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Director/Board Member | - | - |
Northern Scientific, Inc. | President | - | - |
Training of Jeffrey N. Meshulam
State University of New York at Buffalo | Undergraduate Degree |
Statistics
International
United States | 8 |
Operational
President | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
Profectus BioSciences, Inc.
![]() Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Institute of Human Virology
![]() Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Consumer Services |
Northern Scientific, Inc. | |
Cellular Products, Inc.
![]() Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Health Technology |
American Diabetes Association
![]() American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
International Retrovirology Association |
- Stock Market
- Insiders
- Jeffrey N. Meshulam
- Experience